Amyloid aggregation of lysozyme: The synergy study of red wine polyphenols

The amyloidoses are diseases associated with nonnative folding of proteins and characterized by the presence of protein amyloid aggregates. The ability of quercetin, resveratrol, caffeic acid, and their equimolar mixtures to affect amyloid aggregation of hen egg white lysozyme in vitro was detected by Thioflavin T fluorescence assay. The anti‐amyloid activities of tested polyphenols were evaluated by the median depolymerization concentrations DC50 and median inhibition concentrations IC50. Single substances are more efficient (by at least one order) in the depolymerization of amyloid aggregates assay than in the inhibition of the amyloid formation with IC50 in 10−4 to 10−5M range. Analyzed mixture samples showed synergic or antagonistic effects in both assays. DC50 values ranged from 10−5 to 10−8M and IC50 from 10−5 to 10−9M, respectively. We observed that certain mixtures of studied polyphenols can synergistically inhibit production of amyloids aggregates and are also effective in depolymerization of the aggregates. Synergic or antagonistic effects of studied mixtures were correlated with protein–small ligand docking studies and AFM results. Differences in these activities could be explained by binding of each polyphenol to a different amino acid sequence within the protein. Our results indicate that synergic/antagonistic anti‐amyloid effects of studied mixtures depend on the selective binding of polyphenols to the known amyloidogenic sequences in the lysozyme chain. Our findings of the effective reduction of amyloid aggregation of lysozyme by polyphenol mixtures in vitro are of the utter physiological relevance considering the bioavailability and low toxicity of tested phenols. Proteins 2013; © 2012 Wiley Periodicals, Inc.

[1]  G. Pasinetti,et al.  Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  A. Atanasov,et al.  Synergy Study of the Inhibitory Potential of Red Wine Polyphenols on Vascular Smooth Muscle Cell Proliferation , 2012, Planta Medica.

[3]  S. Martín-Aragón,et al.  Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. , 2011, Life sciences.

[4]  J. Dordick,et al.  Polyphenolic Glycosides and Aglycones Utilize Opposing Pathways To Selectively Remodel and Inactivate Toxic Oligomers of Amyloid β , 2011, Chembiochem : a European journal of chemical biology.

[5]  Aurélien Grosdidier,et al.  SwissDock, a protein-small molecule docking web service based on EADock DSS , 2011, Nucleic Acids Res..

[6]  P. Williams,et al.  Natural products as a source of Alzheimer's drug leads. , 2011, Natural product reports.

[7]  Sunan Wang,et al.  Synergistic, additive, and antagonistic effects of food mixtures on total antioxidant capacities. , 2011, Journal of agricultural and food chemistry.

[8]  T. Walle Bioavailability of resveratrol , 2011, Annals of the New York Academy of Sciences.

[9]  P. Aracena-Parks,et al.  Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects. , 2010, Chemico-biological interactions.

[10]  Chin-Giaw Lim and Mattheos A.G. Koffas Bioavailability and Recent Advances in the Bioactivity of Flavonoid and Stilbene Compounds , 2010 .

[11]  M. Masserini,et al.  Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease. , 2010, Current medicinal chemistry.

[12]  A. Masunov,et al.  Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer. , 2010, Biophysical chemistry.

[13]  J. McLaurin,et al.  Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention , 2010, Experimental Neurology.

[14]  J. Dordick,et al.  Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers* , 2010, The Journal of Biological Chemistry.

[15]  P. Carrupt,et al.  Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity* , 2010, The Journal of Biological Chemistry.

[16]  A. Murase,et al.  Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. , 2009, The American journal of pathology.

[17]  Lei Huang,et al.  Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. , 2009, Neurotoxicology.

[18]  A. Falcão,et al.  Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. , 2009, Molecular nutrition & food research.

[19]  S. Joo,et al.  Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. , 2009, Life sciences.

[20]  Jeong-Yeh Yang,et al.  Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. , 2008, Life sciences.

[21]  R. Quirion,et al.  Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. , 2008, Mini reviews in medicinal chemistry.

[22]  L. Opie,et al.  The red wine hypothesis: from concepts to protective signalling molecules. , 2007, European heart journal.

[23]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[24]  Kenjiro Ono,et al.  The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. , 2007, Biochemistry.

[25]  Tristan Richard,et al.  Inhibitory activity of stilbenes on Alzheimer’s β-amyloid fibrils in vitro , 2007 .

[26]  E. Gazit,et al.  The molecular mechanisms of the anti-amyloid effects of phenols , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[27]  Jun Wang,et al.  Moderate consumption of Cabernet Sauvignon attenuates A� neuropathology in a mouse model of Alzheimer's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  R. Andriantsitohaina,et al.  Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. , 2006, Cardiovascular & hematological agents in medicinal chemistry.

[29]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[30]  Christopher M. Dobson,et al.  Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms , 2006, The Journal of Neuroscience.

[31]  E. Mandelkow,et al.  Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy , 2006, Journal of Biological Chemistry.

[32]  Peter Davies,et al.  Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.

[33]  S. Percival,et al.  Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. , 2005, Cancer letters.

[34]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[35]  Angelo Fontana,et al.  A highly amyloidogenic region of hen lysozyme. , 2004, Journal of molecular biology.

[36]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[37]  Jia Huang,et al.  Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme. , 2004, Biomacromolecules.

[38]  V. Uversky,et al.  Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.

[39]  D. Tagliazucchi,et al.  Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin , 2003, Brain Research Bulletin.

[40]  Y. Yonezawa,et al.  Effects of salt concentration on association of the amyloid protofilaments of hen egg white lysozyme studied by time-resolved neutron scattering. , 2003, Journal of molecular biology.

[41]  M. Benson,et al.  A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. , 2003, Kidney international.

[42]  G. Rottinghaus,et al.  Resveratrol protects against global cerebral ischemic injury in gerbils , 2002, Brain Research.

[43]  S. Ferreira,et al.  β-Amyloid Production, Aggregation, and Clearance as Targets for Therapy in Alzheimer's Disease , 2002, Cellular and Molecular Neurobiology.

[44]  C. Scaccini,et al.  Coffee drinking influences plasma antioxidant capacity in humans. , 2002, Journal of agricultural and food chemistry.

[45]  Ž. Eva Amyloid-fibril formation: Proposed mechanisms and relevance to conformational disease , 2002 .

[46]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[47]  Ehud Gazit,et al.  A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  C. Dobson The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[49]  Yun-Lian Lin,et al.  The Neuroprotective Effects of Phytoestrogens on Amyloid β Protein-induced Toxicity Are Mediated by Abrogating the Activation of Caspase Cascade in Rat Cortical Neurons* , 2001, The Journal of Biological Chemistry.

[50]  C M Dobson,et al.  Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. , 2000, Journal of molecular biology.

[51]  J. Rajfer,et al.  Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. , 1999, Urology.

[52]  W. Schaffner,et al.  Phytoestrogen kaempferol (3,4′,5,7‐tetrahydroxyflavone) protects PC12 and T47D cells from β‐amyloid–induced toxicity , 1999, Journal of neuroscience research.

[53]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Commenges,et al.  Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.

[55]  D. Dickstein,et al.  Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. , 2009, Journal of Alzheimer's disease : JAD.

[56]  C. Nerelius Protein misfolding and amyloid formation , 2009 .

[57]  J. Sipe Amyloid proteins : the beta sheet conformation and disease , 2005 .

[58]  S. Ferreira,et al.  Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. , 2002, Cellular and molecular neurobiology.

[59]  E. Žerovnik,et al.  Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. , 2002, European journal of biochemistry.